Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Biomarkers for the detection of bladder cancer
Autore:
Ross, JS; Cohen, MB;
Indirizzi:
Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA Albany Med Coll Albany NY USA 12208 athol & Lab Med, Albany, NY 12208 USA Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA Univ Iowa Iowa City IA USA 52242 ed, Dept Pathol, Iowa City, IA 52242 USA Univ Iowa, Coll Med, Dept Urol, Iowa City, IA 52242 USA Univ Iowa Iowa City IA USA 52242 Med, Dept Urol, Iowa City, IA 52242 USA Vet Affairs Med Ctr, Iowa City, IA 52242 USA Vet Affairs Med Ctr Iowa City IA USA 52242 d Ctr, Iowa City, IA 52242 USA
Titolo Testata:
ADVANCES IN ANATOMIC PATHOLOGY
fascicolo: 1, volume: 8, anno: 2001,
pagine: 37 - 45
SICI:
1072-4109(200101)8:1<37:BFTDOB>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Soggetto:
TRANSITIONAL-CELL-CARCINOMA; FIBROBLAST GROWTH-FACTOR; NUCLEAR MATRIX PROTEIN-22; IN-SITU HYBRIDIZATION; VOIDED URINE CYTOLOGY; IMPROVE DIAGNOSTIC-ACCURACY; AUTOCRINE MOTILITY FACTOR; BARD BTA TEST; IMAGE-ANALYSIS; FOLLOW-UP;
Keywords:
bladder cancer; biomarkers; prognostic factors;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
115
Recensione:
Indirizzi per estratti:
Indirizzo: Ross, JS Albany Med Coll, Dept Pathol & Lab Med, Mail Code 81,New ScotlandAve, Albany, NY 12208 USA Albany Med Coll Mail Code 81,New Scotland Ave Albany NY USA 12208
Citazione:
J.S. Ross e M.B. Cohen, "Biomarkers for the detection of bladder cancer", ADV ANAT PA, 8(1), 2001, pp. 37-45

Abstract

In this subject review, a series of morphology-based and molecular markerswere compared with urinary cytology for the detection of recurrent urothelial neoplasia. Among the various biomarkers reviewed, the average publishedsensitivity and specificity for the Bard BTA test was 60% and 77%; the NMP22 Test was 67% and 72%; the telomerase assay was 77% and 85%; and the microsatellite assay was 89% and 100%. DNA ploidy measurements and immunoassaysdesigned to detect keratins. proteins, hyaluronidase, growth factors, celladhesion molecules, fibrinogen degradation products, cell cycle regulators, and molecular markers were also included. Although the performance features of these biomarkers have varied and the cytologic methods to which they have been compared have not been standardized, several of the procedures have received considerable support from urologists as assisting them in the management of their patients.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 10:01:36